Clinical Trials Logo

Parkinsons Disease clinical trials

View clinical trials related to Parkinsons Disease.

Filter by:

NCT ID: NCT01941732 Completed - Clinical trials for Erectile Dysfunction

Motor Response to Sildenafil in PD

Start date: November 2003
Phase: Phase 4
Study type: Interventional

Sildenafil (Viagra(R))is widely used by men with Parkinsons Disease (PD) and erectile dysfunction. A number of patients have reported that when they take Sildenafil, their need of anti-PD medication is reduced. We hypotheses that sildenafil increases brain blood flow and hence improves the function of specific brain regions, improving motor function. Motor function and cerebral blood flow of 8 patients will be tested before and after Sildenafil intake and before and after anti-PD medication.

NCT ID: NCT01789385 Completed - Parkinsons Disease Clinical Trials

Anesthesia for Deep Brain Stimulation

Start date: February 2013
Phase: Phase 4
Study type: Interventional

Deep brain stimulation for the treatment of Parkinson's disease has unique surgical stages and anesthesia needs. In the first stage the electrodes are inserted in the targeted brain areas and in the second stage the pulse generator is implanted. The technique for establishing sedation and analgesia for functional neurosurgery may differ among institutions. In this study it was aimed to investigate our anesthesia methods, intra-operative adverse events in the first stage of deep brain stimulation and the post operative pain therapy of the patients.

NCT ID: NCT01417598 Active, not recruiting - Osteoporosis Clinical Trials

BETA Study: Improving Balance Function in Elderly by Progressive and Specific Training and Physical Activity

BETA
Start date: January 2010
Phase: N/A
Study type: Interventional

Balance control, physical activity and health related quality of life will be assessed before and after a 10 to 12 weeks training program as well as 6 and 12 months thereafter in 200 elderly (>60) with balance problems (100 with osteoporosis, 100 with Parkinson's disease). Osteoporosis subjects will be assigned to 3 groups (balance training, balance training and Nordic walking, or control group) and Parkinson's subjects to 2 groups (balance training or a control group). The training will be progressive and specific incorporating dual task exercises (directly related to an increased risk of falling). Clinical and laboratory gait and balance measures as well as questionnaires will be used to assess physical function and quality of life. An earlier study, investigating this training program in healthy elderly with balance problems showed that the training was well-tolerated and effective, with a significant increase in balance control, physical function and activity. In this study, we expect that an improvement in balance function, physical activity and health related quality of life, which will lead to a decreased number of falls, prevent and/or postpone incidence of a hazardous fall and thereby reduce the burden on the health care system. Our model for functional balance training and outcome methods will expand techniques and tools available to physical therapists and health care scientist treating and evaluating patients with loss of balance function. Elderly receiving therapy with the goal to improve or recuperate physical function and balance will benefit from this project.

NCT ID: NCT01360229 Completed - Parkinsons Disease Clinical Trials

Acupuncture for Fatigue in Parkinson's Disease

Start date: August 2010
Phase: N/A
Study type: Interventional

This is a single-center, double-blind, placebo-controlled trial to see if acupuncture can safety and effectively treat fatigue in Parkinson's Disease (PD). Eligible subjects will receive either real or sham acupuncture twice weekly for six weeks.

NCT ID: NCT01256905 Withdrawn - Parkinsons Disease Clinical Trials

Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies

Armodafinil
Start date: January 1, 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if a drug commonly used to treat excessive day-time sleepiness, called armodafinil (Nuvigil), is also effective in improving the impairment in the attention commonly reported by patients with more advanced Parkinson's disease (PD) and Lewy body disease (LBD).

NCT ID: NCT01163344 Completed - Parkinsons Disease Clinical Trials

Dance Exercise as Novel Complementary Therapy for Parkinson's Disease

DANCE-PD
Start date: July 2010
Phase: N/A
Study type: Observational

The purpose of this study is to gather data to see if so-called enriched forms of exercise programs such as dance is more effective in improving balance and quality of life in patients with idiopathic Parkinson's disease than regular exercise programs that are currently provided by physical therapists.